Growing community of inventors

Harlow, United Kingdom

Martin C Jones

Average Co-Inventor Count = 7.50

ph-index = 5

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 52

Martin C JonesDavid Richard Witty (5 patents)Martin C JonesChristopher Norbert Johnson (4 patents)Martin C JonesMervyn Thompson (4 patents)Martin C JonesStephen Frederick Moss (4 patents)Martin C JonesGregor James MacDonald (4 patents)Martin C JonesMahmood Ahmed (4 patents)Martin C JonesCharles Edward Wade (4 patents)Martin C JonesMohammad Tadayyon (1 patent)Martin C JonesDieter Hamprecht (1 patent)Martin C JonesSula Anne Armstrong (1 patent)Martin C JonesKamal A Al-Barazanji (1 patent)Martin C JonesGregor James Macdonald (0 patent)Martin C JonesMartin C Jones (5 patents)David Richard WittyDavid Richard Witty (13 patents)Christopher Norbert JohnsonChristopher Norbert Johnson (62 patents)Mervyn ThompsonMervyn Thompson (54 patents)Stephen Frederick MossStephen Frederick Moss (14 patents)Gregor James MacDonaldGregor James MacDonald (13 patents)Mahmood AhmedMahmood Ahmed (7 patents)Charles Edward WadeCharles Edward Wade (6 patents)Mohammad TadayyonMohammad Tadayyon (27 patents)Dieter HamprechtDieter Hamprecht (24 patents)Sula Anne ArmstrongSula Anne Armstrong (1 patent)Kamal A Al-BarazanjiKamal A Al-Barazanji (1 patent)Gregor James MacdonaldGregor James Macdonald (0 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Glaxo Group Limited (4 from 1,168 patents)

2. Smithkline Beecham Corporation (1 from 2,198 patents)


5 patents:

1. 8236947 - [object Object]

2. 7977337 - Quinoline derivatives and their use as 5-HT6 ligands

3. 7799774 - [object Object]

4. 7452888 - Quinoline derivatives and their use as 5-ht6 ligands

5. 7220777 - Lactam derivatives as antagonists for human 11cby receptors

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
1/3/2026
Loading…